Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases

Thromb Res. 2020 Oct:194:116-118. doi: 10.1016/j.thromres.2020.06.032. Epub 2020 Jun 19.

Abstract

  1. We report four non-hospitalized COVID-19 patients who developed VTE in their course of illness.

  2. None of our patients had major risk factors for developing VTE.

  3. A secondary respiratory worsening of COVID-19 should prompt investigation for the occurrence of VTE.

  4. The use of thromboprohylaxis should be considered in bedridden non-hospitalized patients.

  5. Immobilization may be a major risk factor for developing COVID-19Immobilization may be a major risk factor for developing COVID-19.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Ambulatory Care*
  • Bed Rest / adverse effects
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / therapy
  • Factor Xa Inhibitors / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / drug therapy
  • Pulmonary Embolism / etiology*
  • Pyrazoles / therapeutic use
  • Pyridines / therapeutic use
  • Pyridones / therapeutic use
  • Risk Factors
  • Thiazoles / therapeutic use
  • Treatment Outcome
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / etiology*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / etiology*

Substances

  • Factor Xa Inhibitors
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • apixaban
  • edoxaban